AN OBSERVATIONAL STUDY ON DRUG-DRUG INTERACTIONS IN THE CRITICAL CARE UNIT OF A TERTIARY CARE HOSPITAL

Background: Polypharmacy among critically ill patients significantly elevates the risk of drug-drug interactions (DDIs), which can compromise patient safety and clinical outcomes. Understanding the prevalence and impact of these interactions is crucial for enhancing patient safety, optimizing therapeutic efficacy, and minimizing adverse events. Effective DDI management necessitates diligent monitoring, medication reconciliation, and informed clinical decision-making.